YTHDC2 upregulates in colon cancer and has an obviously positive correlation with tumor stage, indicating YTHDC2 may be a diagnostic marker for colon cancer patients (Tanabe et al., 2016). Here, YTHDC2 is linked to malignant colon neoplasm.